MARKET

MRK

MRK

Merck & Co
NYSE

Real-time Quotes | Nasdaq Last Sale

74.62
+0.05
+0.07%
After Hours: 74.50 -0.12 -0.16% 19:08 02/25 EST
OPEN
74.21
PREV CLOSE
74.57
HIGH
75.00
LOW
74.08
VOLUME
10.40M
TURNOVER
--
52 WEEK HIGH
87.80
52 WEEK LOW
65.25
MARKET CAP
188.79B
P/E (TTM)
26.82
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Merck says FDA requires more data on its COVID-19 drug
reuters.com · 1h ago
Merck Makes Another Move to Beef Up Drug Business
Acquisition of Pandion Therapeutics the fourth in past two years
GuruFocus.com · 2h ago
10-K: MERCK & CO., INC.
Edgar Online - (EDG = 10Q, 10K) · 2h ago
Merck Animal Health Completes Acquisition of Poultry Sense Limited
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK),...
BusinessWire - BZX · 2h ago
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
BERKELEY HEIGHTS, N.J., Feb 25, 2021 (GLOBE NEWSWIRE via COMTEX) -- BERKELEY HEIGHTS, N.J., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc....
GlobeNewswire · 3h ago
Global cancer immunotherapy market valuation to cross USD 1 billion by 2026
Feb 25, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report LLC: According to the recent research report titled 'Cancer Immunotherapy...
Market Insight Reports · 5h ago
Endocrinology Drugs Market Analysis, Revenue, Price, Market Share, Growth Rate, Forecast to 2025
Feb 25, 2021 (Market Insight Reports) -- Selbyville, Delaware Market Study Report LLC recently added a new title on Endocrinology Drugs Market Report from...
Market Insight Reports · 5h ago
UPDATE 1-JPMorgan CEO of Chase consumer banking leaving to head TIAA
UPDATE 1-JPMorgan CEO of Chase consumer banking leaving to head TIAA
reuters.com · 6h ago
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MRK. Analyze the recent business situations of Merck & Co through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average MRK stock price target is 96.33 with a high estimate of 107.00 and a low estimate of 79.00.
EPS
Institutional Holdings
Institutions: 3.37K
Institutional Holdings: 1.99B
% Owned: 78.66%
Shares Outstanding: 2.53B
TypeInstitutionsShares
Increased
1.17K
71.23M
New
361
2.24M
Decreased
873
83.36M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.83%
Pharmaceuticals & Medical Research
-1.34%
Key Executives
Chairman/Chief Executive Officer/President/Director
Kenneth Frazier
Chief Financial Officer/Executive Vice President
Robert Davis
Chief Human Resource Officer/Executive Vice President
Steven Mizell
Executive Vice President/Chief Marketing Officer
Michael Nally
Executive Vice President/General Counsel/Secretary
Jennifer Zachary
Executive Vice President
Sanat Chattopadhyay
Executive Vice President
Frank Clyburn
Executive Vice President
Franklin Clyburn
Executive Vice President
Richard DeLuca
Executive Vice President
Julie Gerberding
Executive Vice President
Dean Li
Senior Vice President - Finance/Controller
Rita Karachun
Senior Vice President/Chief Compliance Officer
Michael Fleming
Lead Director/Independent Director
Leslie Brun
Independent Director
Thomas Cech
Independent Director
Mary Coe
Independent Director
Pamela Craig
Independent Director
Thomas Glocer
Independent Director
Paul Rothman
Independent Director
Patricia Russo
Independent Director
Christine Seidman
Independent Director
Inge Thulin
Independent Director
Kathy Warden
Independent Director
Peter Wendell
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
01/26/2021
Dividend USD 0.65
03/12/2021
11/17/2020
Dividend USD 0.65
12/14/2020
07/28/2020
Dividend USD 0.61
09/14/2020
05/26/2020
Dividend USD 0.61
06/12/2020
01/28/2020
Dividend USD 0.61
03/13/2020
11/19/2019
Dividend USD 0.61
12/13/2019
07/23/2019
Dividend USD 0.55
09/13/2019
05/28/2019
Dividend USD 0.55
06/14/2019
01/29/2019
Dividend USD 0.55
03/14/2019
10/25/2018
Dividend USD 0.55
12/14/2018
07/24/2018
Dividend USD 0.48
09/14/2018
05/22/2018
Dividend USD 0.48
06/14/2018
01/23/2018
Dividend USD 0.48
03/14/2018
11/28/2017
Dividend USD 0.48
12/14/2017
07/26/2017
Dividend USD 0.47
09/14/2017
05/23/2017
Dividend USD 0.47
06/13/2017
03/01/2017
Dividend USD 0.47
03/13/2017
11/22/2016
Dividend USD 0.47
12/13/2016
07/26/2016
Dividend USD 0.46
09/13/2016
05/24/2016
Dividend USD 0.46
06/13/2016
02/23/2016
Dividend USD 0.46
03/11/2016
11/24/2015
Dividend USD 0.46
12/11/2015
07/22/2015
Dividend USD 0.45
09/11/2015
05/26/2015
Dividend USD 0.45
06/11/2015
02/24/2015
Dividend USD 0.45
03/12/2015
11/25/2014
Dividend USD 0.45
12/11/2014
07/23/2014
Dividend USD 0.44
09/11/2014
05/27/2014
Dividend USD 0.44
06/12/2014
02/25/2014
Dividend USD 0.44
03/13/2014
11/26/2013
Dividend USD 0.44
12/12/2013
07/25/2013
Dividend USD 0.43
09/12/2013
About MRK
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Webull offers kinds of Merck & Co., Inc. stock information, including NYSE:MRK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRK stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MRK stock methods without spending real money on the virtual paper trading platform.